Redensyl vs Procapil vs Anagain: Which Hair Serum Ingredient Should You Choose?

Redensyl, Procapil, and Anagain are all patented cosmetic ingredients used in hair growth serums. All three have small manufacturer-sponsored studies behind them. None are approved for hair loss treatment by any drug regulatory authority, and none have the volume or depth of evidence that established treatments like minoxidil carry. They can be reasonable low-risk options for mild shedding or as complements to clinical treatment. For confirmed, progressing androgenetic alopecia, a dermatologist evaluation is more important than choosing between these three ingredients.

At a Glance

Pharmacy shelves and dermatology-adjacent Instagram pages are full of hair serums claiming to contain ingredients clinically proven to stop hair fall. Redensyl, Procapil, and Anagain are three names that appear most often on these labels. All three are legitimate patented compounds with biological rationale and some supporting research. All three are also, at this point in the evidence base, cosmetic ingredients with limited independent clinical data.

If you are trying to choose between them, the honest answer is that the ingredient on the label matters less than the diagnosis behind the hair loss. But if you want to understand what each compound actually does and what the evidence shows, this article gives you a clear clinical comparison.

Trying different serums and not seeing results? The issue may not be the ingredient. It may be a diagnosis that no serum can address. HairMD’s trichoscopy assessment identifies what is actually driving your hair loss. Call or find us on Google Maps.

Redensyl was developed by Givaudan and introduced in 2014. It targets two cell populations in the hair follicle:

• DHQG (dihydroquercetin-glucoside): Acts on LRIG1-positive stem cells in the outer root sheath, which are involved in triggering follicle re-entry into the growth phase.
• EGCG2 (epigallocatechin-gallate-glucoside): Targets dermal papilla cells to reduce inflammation and support follicle cell activity.

The Evidence

The primary clinical study involved 26 subjects over 84 days. It reported a 17% reduction in hair loss and a 9% increase in the proportion of hairs in the anagen (growth) phase compared to placebo. This is a small, short, manufacturer-sponsored trial with no large-scale independent replication.

Redensyl is regulated as a cosmetic ingredient, not a drug. It does not make hair fall stop in a clinical or regulatory sense; it may support follicle health in a supportive, cosmetic sense.

Redensyl vs Minoxidil vs GFC: Which Hair Treatment Is Right for You?

Procapil was developed by Sederma and is a combination of three components designed to work through different mechanisms simultaneously:

• Biotinoyl Tripeptide-1: A biotin-containing peptide that mimics the activity of a natural protein called laminin-5, which anchors the hair bulb to the follicle. In theory, this reduces the likelihood of the hair shaft detaching prematurely.
• Apigenin: A flavonoid derived from citrus that is proposed to improve scalp microcirculation, which in theory increases nutrient and oxygen delivery to follicle cells.
• Oleanolic acid: Derived from olive leaves, proposed to inhibit 5-alpha reductase, the enzyme that converts testosterone to DHT. DHT is the primary driver of androgenetic alopecia.

The Evidence

Procapil’s manufacturer claims a 46% reduction in hair loss and a 121% increase in the anagen growth phase based on their proprietary testing on 35 volunteers over four months. These figures are from internal testing, not peer-reviewed independent trials. The oleanolic acid component’s DHT-inhibiting effect in a topical cosmetic formulation has not been confirmed at the level of clinical hair loss treatment.

Procapil is frequently included in serums marketed for androgenetic alopecia because of the DHT-inhibition claim, but its actual effect on confirmed AGA in independent clinical populations is not established.

Anagain was developed by Mibelle Group and is derived from organic pea sprout extract (Pisum sativum). The proposed mechanism is different from the other two: rather than targeting stem cells or blocking DHT, Anagain is claimed to reactivate follicle papilla cells in a way that shifts the balance between anagen (growth) and telogen (resting) hairs.

Specifically, Anagain is reported to upregulate gene expression in dermal papilla cells that are associated with the anagen phase, including FGF-7 (a fibroblast growth factor that supports hair growth signaling).

The Evidence

The manufacturer reports a 78% increase in the anagen-to-telogen hair ratio after 3 months in 20 volunteers. This is a very small study population. Anagain has not been independently replicated in larger or peer-reviewed trials. It is regulated as a cosmetic ingredient.

Mechanism

All three take different approaches to the same problem:

• Redensyl targets follicle stem cell activation
• Procapil combines DHT inhibition, microcirculation support, and a biotin-peptide anchor mechanism
• Anagain aims to shift the anagen-to-telogen ratio through growth factor gene expression in dermal papilla cells

These mechanisms are biologically plausible. The question is whether the concentrations used in commercial cosmetic formulations are sufficient to produce the proposed effects at the follicle level in humans with established hair loss conditions.

Evidence Quality

All three share the same limitation: small, short, manufacturer-sponsored studies with no large independent clinical replication.

For context: minoxidil’s evidence base spans hundreds of randomized controlled trials across tens of thousands of patients over more than four decades. These three ingredients are at early stages of their evidence journey.

Regulatory Status

None of the three are approved as hair loss treatments by CDSCO (India’s drug regulator), the FDA, or the EMA. They are cosmetic ingredients that can be included in personal care products with certain claim restrictions. In India, cosmetic claims cannot state that a product “treats” or “cures” hair loss.

Yes. Many commercial hair serums in India include two or all three of these ingredients alongside other actives. There is no known pharmacological reason they should not be combined, and their different mechanisms suggest potential complementary activity.

Some serums also combine these with minoxidil, which is a drug requiring its own regulatory classification. If a product contains both a cosmetic ingredient and a drug-classified active, it should be treated as a drug product and handled under medical supervision.

Dr. Dhanraj Chavan, senior dermatologist at HairMD, explains his clinical perspective: “A patient comes in after 4 or 5 months using an expensive serum that has Redensyl, Procapil, Anagain, and probably two or three other branded compounds. They are frustrated because they expected results and are not seeing them. My question is always: what is the actual diagnosis? Because if someone has androgenetic alopecia and they spend several months using cosmetic serums, those months matter. AGA is a progressive condition. Early intervention with evidence-backed treatment produces meaningfully better outcomes than delayed treatment with unvalidated cosmetic alternatives. The serums are not harmful. The delay is.”

Frustrated after months of trying hair serums? A trichoscopy at HairMD gives you a clear diagnosis in one visit — so your next step is based on evidence, not trial and error. Clinics across Aundh, Baner, Kothrud, Wakad, Viman Nagar, Hadapsar, and Pimple Saudagar.  HairMD today.

These ingredients may be appropriate in the following situations:

• Very early or mild diffuse shedding without a confirmed androgenetic alopecia diagnosis, where a low-risk supportive approach is reasonable while monitoring
• As a complement to clinical treatment, where minoxidil or GFC therapy is the primary intervention and a serum adds supportive scalp care
• Scalp health maintenance in people without active hair loss who want to support follicle environment as a preventive habit
• Patients who cannot tolerate minoxidil due to scalp sensitivity, who want a topical option with a different mechanism while seeking clinical alternatives

These serums are typically not appropriate as primary treatments for:

• Confirmed androgenetic alopecia that is progressing
• Telogen effluvium driven by nutritional deficiency or hormonal imbalance (the root cause needs to be addressed)
• Moderate to advanced hair loss where follicle miniaturization is significant

(Related: Is Rosemary Oil Enough for Hair Regrowth? When to Consider Something Stronger)

If you have been using one or more of these serum ingredients for 4 to 6 months without improvement in shedding or density, the product is not failing you. The product is telling you something: the type of hair loss you have is unlikely to respond to a cosmetic-level intervention alone.

The next steps in a clinical escalation pathway include:

• Trichoscopy: To establish the hair loss type and follicle status (Related: What Is Trichoscopy and Why Does It Matter for Hair Loss Diagnosis?)
• Blood panel: To identify nutritional or hormonal contributors
• Minoxidil: First-line topical for confirmed AGA
• GFC or PRP therapy: For moderate hair loss or to accelerate response (Related: GFC vs PRP: Which Is Better for Reducing Hair Fall?)
• Oral medications: For AGA driven by DHT (finasteride, dutasteride, spironolactone depending on sex and clinical picture)

At HairMD, serum ingredients are evaluated in the context of a diagnosis, not as standalone solutions. A patient using Redensyl, Procapil, or Anagain receives an assessment of whether those choices are appropriate for their specific hair loss type, and if not, a transition plan to evidence-based treatment.

A standard evaluation includes trichoscopy, a targeted blood panel, a detailed hair loss history, and a treatment plan built on clinical findings rather than product preferences.

Step 1: Visit any HairMD clinic in Pune — Aundh, Baner, Kothrud, Wakad, Viman Nagar, Hadapsar, or Pimple Saudagar.

Step 2: Get a trichoscopy and blood panel with Dr. Dhanraj Chavan to identify your hair loss type and any nutritional or hormonal contributors.

Step 3: Start a treatment plan matched to your diagnosis, whether that includes these serums as a complement or moves to clinical treatment.

Call  | Find HairMD on Google Maps

Redensyl, Procapil, and Anagain are legitimate patented cosmetic ingredients with biologically plausible mechanisms and small supporting studies. All three are cosmetic-grade compounds regulated under personal care product rules, not hair loss drugs. Their evidence base is preliminary and not independently replicated at scale.

They may provide supportive value for mild cases or as complements to established treatment, but are not validated substitutes for clinical treatment in confirmed, progressing androgenetic alopecia. The decision between these three ingredients matters less than getting a clear diagnosis and matching the treatment to the hair loss type.

Which is more effective: Redensyl, Procapil, or Anagain?

All three have small manufacturer-sponsored studies with encouraging results, but none have been compared head-to-head in an independent clinical trial. Redensyl has the most widely cited study. Procapil has the broadest range of mechanisms claimed. Anagain targets a different aspect of the hair cycle. Without independent comparative data, it is not possible to rank them by effectiveness.

Can I use Redensyl, Procapil, and Anagain together?

Yes. There is no known pharmacological incompatibility between the three. Many commercial serums in India already combine all three. Their different proposed mechanisms suggest potential complementary action, though combined-formula studies are also limited.

Are these ingredients safe for daily use?

Generally yes. All three are cosmetic ingredients with established safety profiles at typical usage concentrations. Skin irritation or contact allergy is possible in sensitive individuals. Perform a patch test before full scalp application, particularly if you have a history of product sensitivity.

Do Redensyl or Procapil block DHT like finasteride does?

Not at a clinically validated level. Redensyl has a partial DHT-inhibition claim based on its rosmarinic acid content. Procapil contains oleanolic acid, which has shown 5-alpha reductase inhibition in laboratory settings. Neither compound has been shown to produce meaningful DHT blockade in human clinical trials at cosmetic serum concentrations. Finasteride and dutasteride are oral medications that produce documented, measurable reductions in scalp DHT.

Is Procapil better for hair loss than Redensyl?

There is no direct comparative trial between the two. Procapil’s multi-mechanism approach (DHT inhibition + microcirculation + biotin peptide) makes a broader theoretical claim. Redensyl’s evidence comes from a slightly more rigorously described study methodology. In the absence of head-to-head data, neither can be definitively said to outperform the other.

How long should I use these serums before expecting results?

A minimum of 3 to 6 months of consistent daily use is needed before meaningful assessment. At 6 months without improvement in shedding or density, a dermatologist evaluation is recommended to identify whether the hair loss type responds to cosmetic-level intervention or requires clinical treatment.

Can these serums be used alongside minoxidil? Yes. None of the three ingredients have known interactions with minoxidil. Apply them as part of your scalp care routine separately from minoxidil application. Avoid mixing essential oils or unfamiliar compounds directly into a minoxidil formulation, as this can alter absorption and cause irritation.

Do these serums work for female hair loss?

The existing small studies for all three included both male and female participants, but no ingredient has been studied specifically in female androgenetic alopecia populations at scale. For women with confirmed female pattern hair loss, minoxidil (starting at 2%) is the validated topical option. These serum ingredients can be used alongside it as a complement if a dermatologist considers it appropriate.